IndraLab

Statements



reach
"Hence, we treated cells with cycloheximide, a protein synthesis inhibitor, to block the production of NLRP3 and assessed the protein decay over time."

reach
"To test this hypothesis, we evaluated NLRP3 stability in BMDMs using the protein synthesis pan-inhibitor cycloheximide (CHX), which demonstrated that PV-K treatment (PV-K + LPS + ATP) enhanced NLRP3 degradation (Fig. 6C, D)."

reach
"To further elucidate whether oroxylin A could affect the inflammasome formation in the second step, cycloheximide was given before LPS to block NLRP3 protein synthesis."

reach
"As previously shown, NLRP3 inflammasome activation was critically dependent on the presence of LPS and abrogated by cycloheximide treatment (XREF_FIG, upper panel)."